Pacific Biosciences of California (NASDAQ:PACB) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Pacific Biosciences of California (NASDAQ:PACB – Free Report) from a sell rating to a hold rating in a research note released on Saturday morning. A number of other research firms also recently issued reports on PACB. Stephens restated an “overweight” rating and issued a $1.80 price target on shares […]
More Stories
Musk Says X’s New Algorithm Will Be Open Source in 6 Days
By Jacob Burg Elon Musk said on Jan. 10 that his X social media platform would open its new algorithm...
Trump Urges Cuba to Strike Deal With US After Oil, Money Cut Off From Venezuela
By Jacob Burg U.S. President Donald Trump on Jan. 11 told Cuba that it should forge a deal with the...
Wall Street Review: Stocks Close Out Strong Week on Labor Market Clarity
By Panos Mourdoukoutas Equities resumed their rally this week as investors gained a clearer view of the labor market following...
Protests Spread in Iran as Regime Vows to Retaliate Against Any US Attack
By Jacob Burg The Iranian regime threatened on Jan. 11 to strike Israeli and U.S. military bases if Washington attacks...
ICE Agent Involved in Shooting Is Getting Death Threats, Border Czar Says
By Jack Phillips White House border czar Tom Homan defended Immigration and Customs Enforcement (ICE) amid protests against the agency...
Overhauling Air Traffic Control Involves 5,000 Locations and 600 Radar Systems—What to Know
By Jacob Burg The federal government is embarking on what Transportation Secretary Sean Duffy has called “the most important infrastructure...